Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L T Meltzer

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Psychopharmacology|January 1, 1989
Evaluation in rats of the somnogenic, pyrogenic, and central nervous system depressant effects of muramyl dipeptideL T Meltzer, K A Serpa, W H Moos
Synapse (New York, N.Y.)|June 1, 1997
Metabotropic glutamate receptor-mediated inhibition and excitation of substantia nigra dopamine neuronsL T Meltzer, K A Serpa, C L Christoffersen
European Journal of Pharmacology|October 24, 1989
The alpha 2-adrenoceptor antagonists idazoxan and yohimbine can unmask the postsynaptic dopamine agonist effects of B-HT 920L T Meltzer, J N Wiley, T G Heffner
Neuroscience and Biobehavioral Reviews|July 1, 1997
Modulation of dopamine neuronal activity by glutamate receptor subtypesL T Meltzer, C L Christoffersen, K A Serpa
The Journal of Pharmacology and Experimental Therapeutics|November 21, 2001
Pregabalin enhances nonrapid eye movement sleepT Kubota, J Fang, L T Meltzer, et al.
Pharmacology, Biochemistry, and Behavior|January 1, 1980
Comparison of phencyclidine and three analogues on fixed-interval performance in rhesus monkeysK T Brady, R L Balster, L T Meltzer, et al.
Drug and Alcohol Dependence|March 1, 1977
1-alpha-acetylmethadol (LAAM), methadone and morphine abstinence in dependent rats: EEG and behavioral correlatesG A Young, J E Moreton, L T Meltzer, et al.
Synapse (New York, N.Y.)|February 1, 1993
Comparison of the effects of the cholecystokinin-B receptor antagonist, PD 134308, and the cholecystokinin-A receptor antagonist, L-364,718, on dopamine neuronal activity in the substantia nigra and ventral tegmental areaL T Meltzer, C L Christoffersen, K A Serpa, et al.
Progress in Brain Research|January 1, 1989
Nicotine-induced tolerance and dependence in rats and mice: studies involving schedule-controlled behaviorJ A Rosecrans, C A Stimler, J S Hendry, et al.
Psychopharmacology|January 1, 1988
Evidence for postsynaptic dopamine agonist effects of B-HT 920 in the presence of the dopamine D-1 agonist SKF 38393L T Meltzer, J N Wiley, A E Williams, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Psychopharmacology|January 1, 1989
Evaluation in rats of the somnogenic, pyrogenic, and central nervous system depressant effects of muramyl dipeptideL T Meltzer, K A Serpa, W H Moos
Synapse (New York, N.Y.)|June 1, 1997
Metabotropic glutamate receptor-mediated inhibition and excitation of substantia nigra dopamine neuronsL T Meltzer, K A Serpa, C L Christoffersen
European Journal of Pharmacology|October 24, 1989
The alpha 2-adrenoceptor antagonists idazoxan and yohimbine can unmask the postsynaptic dopamine agonist effects of B-HT 920L T Meltzer, J N Wiley, T G Heffner
Neuroscience and Biobehavioral Reviews|July 1, 1997
Modulation of dopamine neuronal activity by glutamate receptor subtypesL T Meltzer, C L Christoffersen, K A Serpa
The Journal of Pharmacology and Experimental Therapeutics|November 21, 2001
Pregabalin enhances nonrapid eye movement sleepT Kubota, J Fang, L T Meltzer, et al.
Pharmacology, Biochemistry, and Behavior|January 1, 1980
Comparison of phencyclidine and three analogues on fixed-interval performance in rhesus monkeysK T Brady, R L Balster, L T Meltzer, et al.
Drug and Alcohol Dependence|March 1, 1977
1-alpha-acetylmethadol (LAAM), methadone and morphine abstinence in dependent rats: EEG and behavioral correlatesG A Young, J E Moreton, L T Meltzer, et al.
Synapse (New York, N.Y.)|February 1, 1993
Comparison of the effects of the cholecystokinin-B receptor antagonist, PD 134308, and the cholecystokinin-A receptor antagonist, L-364,718, on dopamine neuronal activity in the substantia nigra and ventral tegmental areaL T Meltzer, C L Christoffersen, K A Serpa, et al.
Progress in Brain Research|January 1, 1989
Nicotine-induced tolerance and dependence in rats and mice: studies involving schedule-controlled behaviorJ A Rosecrans, C A Stimler, J S Hendry, et al.
Psychopharmacology|January 1, 1988
Evidence for postsynaptic dopamine agonist effects of B-HT 920 in the presence of the dopamine D-1 agonist SKF 38393L T Meltzer, J N Wiley, A E Williams, et al.
Pageof 5